The mechanism of effect of growth hormone on preadipocyte and adipocyte function

Obesity Reviews - Tập 1 Số 2 - Trang 73-86 - 2000
Sanggeun Nam1, Peter E. Lobie2
1Department of Internal Medicine, Yongdong Severance Hospital, Yonsei University College of Medicine, Dogok-dong 146-92, Kangnam-Ku, Seoul 135-270, Korea.
2Institute of Molecular and Cell Biology, 30 Medical Drive, 117609, Singapore, Republic of Singapore.

Tóm tắt

SummaryGrowth hormone (GH) is not only the major regulator of postnatal somatic growth but also exerts profound effects on body composition through a combination of anabolic, lipolytic and antinatriuretic actions. GH enhancement of the lipolytic activity of adipose tissue in combination with a reduction of triglyceride accumulation via inhibition of lipoprotein lipase activity appears to be the major mechanism by which GH results in a reduction of the total fat mass. Recently, much progress has been made in understanding the molecular mechanism by which GH affects cellular function. This review provides a brief discourse and summary of the mechanism of effects of GH on preadipocyte/adipocyte function. It is intended to provide a functional understanding of the mechanism of action of GH as it relates to adipogenesis and adipocyte function.

Từ khóa


Tài liệu tham khảo

10.1111/j.1651-2227.1994.tb13425.x

10.1210/endo-44-1-71

Scow R., 1959, Effect of growth hormone and thyroxine on growth and chemical composition of muscle, bone and other tissues in thyroidectomized‐hypophysectomized rats., Am J Physiol, 196, 859, 10.1152/ajplegacy.1959.196.4.859

Oberbauer AM, 1997, Body composition of inactivated growth hormone (oMt1a‐oGH) transgenic mice: generation of an obese phenotype., Growth Dev Aging, 61, 169

10.1016/0026-0495(95)90220-1

10.1203/00006450-197409000-00005

10.1111/j.1365-2265.1993.tb00974.x

10.1056/NEJM198912283212605

10.1210/jc.76.2.309

10.1007/BF00496089

10.1136/adc.48.9.725

Snyder DK, 1990, Anabolic effects of growth hormone in obese diet‐restricted subjects are dose dependent., Am J Clin Nutr, 52, 431, 10.1093/ajcn/52.3.431

10.1159/000181870

10.1159/000053211

10.1159/000191338

10.1159/000191337

10.1111/j.1651-2227.1994.tb13422.x

10.1007/978-1-4615-5163-8_2

Carter‐Su C, 1998, Signaling via JAK tyrosine kinases: growth hormone receptor as a model system., Recent Prog Horm Res, 53, 61

10.1507/endocrj.45.Suppl_S41

10.1210/endo-107-2-608

10.3109/107998981809038869

10.1210/endo-110-2-637

10.1210/endo-113-3-1111

Carter‐Su C, 1984, Identification of high affinity growth hormone receptor in rat adipocyte membranes., J Biol Chem, 259, 1099, 10.1016/S0021-9258(17)43571-X

LaFranchi S, 1985, Comparison of growth hormone binding and metabolic response in rat adipocytes of epididymal, subcutaneous, and retroperitoneal origin., Acta Endocrinol Copenh, 110, 50

10.1016/0014-5793(86)80856-0

10.1016/0304-4165(86)90009-7

10.1210/endo-126-6-3076

10.1677/joe.0.1260467

10.1210/endo-129-3-1155

10.1210/endo-129-3-1628

10.1007/BF02990065

10.1016/0303-7207(95)03485-P

10.1111/j.1432-0436.1985.tb00316.x

10.1210/jc.80.7.2154

10.1203/00006450-199509000-00024

Brameld JM, 1996, Effects of growth hormone administration and dietary protein intake on insulin‐like growth factor I and growth hormone receptor mRNA. Expression in porcine liver, skeletal muscle, and adipose tissue., J Anim Sci, 74, 1832, 10.2527/1996.7481832x

10.1111/j.1439-0531.1993.tb00109.x

10.1055/s-2007-1011837

10.1016/S0026-0495(97)90177-3

Waters MJ., 1999, The Handbook of Physiology, 397

10.1210/mend.11.3.9901

10.1210/en.131.6.3083

10.1210/en.136.2.386

10.3181/00379727-206-43764

10.1210/endo-116-5-1796

10.1210/en.134.1.307

10.1210/endo-127-3-1287

10.3181/00379727-206-43739

10.1074/jbc.273.47.31327

10.1074/jbc.275.3.2103

10.1074/jbc.270.24.14685

Ridderstrale M, 1995, Growth hormone stimulates the tyrosine phosphorylation of the insulin receptor substrate‐1 and its association with phosphatidylinositol 3‐kinase in primary adipocytes., J Biol Chem, 279, 3471, 10.1074/jbc.270.8.3471

10.1074/jbc.271.46.29415

10.1210/en.138.10.4301

10.1002/bies.950190608

10.1074/jbc.272.2.1032

10.1074/jbc.273.50.33864

10.1074/jbc.272.28.17694

10.1074/jbc.273.4.2344

10.1210/me.13.1.38

10.1074/jbc.274.50.35553

10.1016/0968-0004(94)90038-8

Okada S, 1997, Growth hormone and insulin stimulate different subsets of protein kinase C isotypes through different mechanisms., Proceedings of the 79th Ann Meet Endocrine Soc, 576

10.1073/pnas.86.4.1148

10.1210/endo-127-5-2099

10.1073/pnas.86.16.6363

Roupas P, 1995, Signalling mechanisms involved in the production of diacylglycerol by growth hormone., Proceedings of the 77th Meet Endocrine Soc, 345

Argetsinger LS, 1996, Mechanism of signalling by growth hormone receptor., Physiol Rev, 76, 1089, 10.1152/physrev.1996.76.4.1089

10.1042/bj3240159

10.1042/bj3150517

10.1152/ajpcell.1996.270.5.C1485

10.1006/bbrc.1994.1940

10.1210/endo-127-1-170

10.1210/en.131.2.772

10.1073/pnas.92.7.2725

10.1016/0092-8674(82)90440-8

10.1210/endo-114-2-527

Hauner H, 1986, Adipogenic factors in human serum promote the adipose conversion of 3T3‐L1 fibroblasts., Int J Obes, 10, 323

10.1042/bj2380123

10.1016/0014-4827(87)90412-5

10.1002/jcp.1041610209

10.1007/BF01727474

10.1007/BF01727475

10.1146/annurev.nu.12.070192.001231

10.1016/S0026-0495(96)90197-3

10.1210/jc.85.4.1412

10.1203/00006450-199609000-00014

10.1210/endo-78-4-819

Carter‐Su C, 1988, Rapid and transitory stimulation of 3‐O‐methylglucose transport by growth hormone., Am J Physiol, 255, E723

10.1152/ajpendo.1980.238.4.E389

10.1210/endo-76-2-216

10.1210/endo-102-1-210

10.1111/j.1651-2227.1990.tb11649.x

10.1007/BF00298723

10.1210/en.137.1.35

10.1210/en.138.7.2849

10.1016/0092-8674(84)90030-8

Murphy WJ, 1992, Role of neuroendocrine hormones in murine T cell development. Growth hormone exerts thymopoietic effects in vivo., J Immunol, 149, 3851, 10.4049/jimmunol.149.12.3851

10.1210/endo-106-2-577

10.1073/pnas.87.19.7507

10.1210/en.136.7.3062

10.1002/(SICI)1097-4652(199710)173:1<44::AID-JCP6>3.0.CO;2-J

10.1074/jbc.274.50.36015

10.1128/MCB.9.10.4196

10.1210/endo-125-5-2360

10.1210/endo-129-1-527

10.1210/en.130.5.2609

10.1074/jbc.273.17.10682

Ilic D, 1997, Focal adhesion kinase: at the crossroads of signal transduction., J Cell Sci, 110, 401, 10.1242/jcs.110.4.401

10.1074/jbc.270.37.21639

10.1074/jbc.274.13.8662

10.1073/pnas.95.7.3549

10.1016/S0303-7207(98)00049-5

10.1038/370223a0

10.1210/endo-127-6-3187

10.1210/en.130.4.2016

10.1210/me.9.1.108

10.1016/S0955-0674(96)80084-6

Padines‐Figueres A, 1990, Transcriptional control of the expression of lipoprotein lipase gene by growth hormone in preadipocyte Ob1771 cells., J Lipid Res, 31, 1283, 10.1016/S0022-2275(20)42637-9

10.1042/bj2390363

10.1002/j.1460-2075.1987.tb02744.x

10.3109/08977199209021538

10.1073/pnas.75.12.6054

10.1002/jcp.1041010119

10.1677/joe.0.1370203

10.1210/mend.12.8.0154

10.1093/nar/22.25.5628

10.1126/science.274.5295.2100

10.1101/gad.2.12b.1723

10.1016/0092-8674(93)90252-L

10.1055/s-0028-1092695

10.1055/s-2007-1019264

Smal J, 1987, Receptor binding properties and insulin‐like effects of human growth hormone and its 20 kDa‐variant in rat adipocytes., J Biol Chem, 262, 11071, 10.1016/S0021-9258(18)60928-7

10.1210/endo-122-5-2247

10.1016/0303-7207(94)90153-8

10.1074/jbc.270.37.21745

VanderKuur JA, 1995, Growth hormone‐dependent phosphorylation of tyrosine 333 and/or 338 of the growth hormone receptor., J Biol Chem, 2, 1738

10.1073/pnas.86.12.4705

10.1016/0014-5793(89)80584-8

10.1210/en.137.11.4650

10.1006/bbrc.1994.2182

LobiePE ZhuT GraichenR GohEL.Growth hormone insulin like growth factor‐1 and the central nervous system: Localization Function and Mechanism of Action.Growth Horm IGF Res2000; in press.

10.1023/A:1006886509892

10.1210/endo-115-3-1151

10.1016/0014-5793(94)00797-7

10.1042/bj2820099

10.1074/jbc.274.15.10071

10.1016/S0303-7207(99)00154-9

Tai PK, 1990, Differential regulation of two glucose transporters by chronic growth hormone treatment of cultured 3T3‐F442A adipose cells., J Biol Chem, 265, 21828, 10.1016/S0021-9258(18)45814-0

10.1677/joe.0.1450027

10.1016/0065-2571(67)90007-6

10.1006/bbrc.1999.1302

10.1016/0006-291X(86)91246-5

10.1042/bj2730039

10.1152/ajpendo.1992.263.3.E467

10.1111/j.1651-2227.1994.tb13423.x

10.1042/bj2890845

10.1073/pnas.81.11.3317

Fain JN, 1970, The involvement of RNA synthesis and cyclic AMP in the activation of fat cell lipolysis by growth hormone and glucocorticoids., Horm Metab Res, 2, 20

Yip RG, 1999, Growth hormone and dexamethasone stimulate lipolysis and activate adenylyl cyclase in rat adipocytes by selectively shifting Gi alpha2 to lower density membrane fractions., Endocrinology, 140, 1219, 10.1210/endo.140.3.6580

10.1016/0026-0495(91)90006-I

10.1210/endo-84-2-414

Slavin BG, 1994, Hormonal regulation of hormone‐sensitive lipase activity and mRNA levels in isolated rat adipocytes., J Lipid Res, 35, 1535, 10.1016/S0022-2275(20)41151-4

10.1677/joe.0.1580295

10.1016/0304-4157(90)90007-Y

Houslay MD., 1994, Regulation of Cellular Signal transduction Pathways by Desensitization and Amplification, 129

10.1042/bj2620403

10.1016/S0167-4889(96)00072-9

10.1042/bj2970041

Doris RA, 1996, Chronic effects of somatotropin treatment on response of subcutaneous adipose tissue lipolysis to acutely acting factors in vivo and in vitro., J Anim Sci, 74, 562, 10.2527/1996.743562x

Goodman HM, 1988, Human Growth Hormone, Progress and Challenges, 75

10.1677/joe.0.1420235

10.1677/joe.0.1500129

10.1152/ajpendo.1994.266.2.E211

10.1210/jc.80.3.936

10.1210/jcem-69-6-1274

10.1038/sj.ijo.0800807

10.1074/jbc.M001972200